Investigation of Various Factors on Ovarian Cancer: A Review Study

Introduction:Ovarian cancer is a type of cancer that starts from the ovary.This disease leads to the creation of abnormal cells that have the ability to invade or spread to other parts of the body.At the beginning of this process, the symptoms may be vague or non-obvious, but as the cancer progresses, the symptoms become more likely.Ovarian cancer patients usually do not have specific symptoms and often go to the doctor with non-specific symptoms such as bloating, pelvic pain, abdominal swelling and other symptoms.Several factors can increase the risk of developing ovarian cancer, including genetic factors, age, use of hormone therapy after menopause, infertility, obesity has been identified as a possible risk factor.Ovarian cancer is 1 in 75 in a woman's lifetime and the chance of her dying from this disease is 1 in 1004.This disease usually shows itself in the final stages, with a 5-year relative survival rate of only 29%.Despite its global health importance, the cause of this deadly disease is not fully understood.Ovarian cancer is the fifth cause of cancer-related death in women and the deadliest female malignancy.The aim of this article is to provide a comprehensive overview of general epidemiology. Conclusion:The possibility of ovarian cancer should be considered for any woman who presents with new and persistent diseases.Ovarian cancer should always be treated according to published guidelines.Appropriate treatment of primary ovarian cancer includes removal of the primary tumor and all macroscopically visible tumor mass, as well as careful inspection.The natural history of ovarian cancer shows that it remains a tumor that takes the lives of women of reproductive age for decades to come.If ovarian cancer is in the early stages and is treated, it may be curable.Treatment usually involves a combination of radiation therapy or chemotherapy.The outcome of the treatment depends on these factors: the extent of the disease and the subtype of cancer, which the person is suffering from.Overall, the five-year survival rate in the United States is about 45 percent.The results are worse in developing countries.Researchers are constantly looking for clues, such as lifestyle, diet, and medications that may change the risk of ovarian cancer.Identification of more accurate molecular biomarkers for early detection of ovarian cancer is an important unmet medical need.CA125 is still the best and most widely used biomarker for early detection of ovarian cancer used in clinics, but it is very limited.